Craig-Hallum Capital Group and The Benchmark Company acted as underwriters in a $19 million public offering and uplisting for Processa Pharmaceuticals, Inc. Faegre Drinker represented the underwriters in the transaction.
Pursuant to the offering, Processa issued 4.8 million shares of common stock at a public offering price of $4.00 per share.
Results may vary depending on your particular facts and legal circumstances.
